Home LiteratureArticle Details
PMID: 23400375 Published · ppublish English Journal Article Randomized Controlled Trial

Seminal plasma insemination during ovum-pickup--a method to increase pregnancy rate in IVF/ICSI procedure. A pilot randomized trial.

Journal of assisted reproduction and genetics ·Vol. 30 ·No. 4 ·2013-04-00 ·Pages 569-74

Chicea R, Ispasoiu F, Focsa M

Abstract

In IVF procedures, endometrial function is a limiting factor of the pregnancy rate and the aims of this study is to determine whether seminal plasma insemination at ovum pick-up in IVF has any effect on pregnancy rate. We designed a single center, 2 parallel groups, randomized pilot study. All couples undergoing an IVF procedure in our clinic between January 2010 and December 2011 were considered for enrollment in the study. The patients who met the inclusion criteria were randomized into two groups by simple randomization: the seminal plasma group (SP group) and the reference group (noSP group). We applied seminal plasma into the cervix and vaginal vault at the time of the OPU in the patients of the SP group. The primary outcome was the clinical pregnancy rate in the SP group compared with the noSP group and the secondary outcome measure was the implantation rate. 400 patients met the inclusion criteria and were randomized. 54 patients were excluded from the study mainly because they didn't undergo the embryo transfer. Finally, 164 patients were included in the SP group and 182 patients in the noSP group and analyzed. We found a statistically non-significant increase in the pregnancy rate in the SP group (55.5 % versus 44 %, p=0.09) and a statistically significant increase in the implantation rate (34.7 % versus 27.5 %, p=0.026). Our results support the idea that SP insemination may have the potential to increase pregnancy rate in IVF procedures but further studies must be carried out.

MeSH Terms
Adult Embryo Transfer Female Humans Pilot Projects Pregnancy Pregnancy Rate Semen Sperm Injections, Intracytoplasmic/methods Sperm-Ovum Interactions
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chicea Radu
University of Medicine, Victor Papilian, Sibiu, Romania.
Ispasoiu Florin
Focsa Mircea
References (20)
20 references, click to expand
  1. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?
    Hum Reprod Update. 2009 Sep-Oct;15(5):517-35 PMID: 19279047
  2. A cytokine switch induced by human seminal plasma: an immune modulation with implications for sexually transmitted disease.
    Hum Reprod. 1997 Apr;12(4):677-81 PMID: 9159423
  3. Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
    Fertil Steril. 2003 Aug;80(2):464-6 PMID: 12909519
  4. Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid.
    J Reprod Immunol. 2009 Dec;83(1-2):109-16 PMID: 19875178
  5. Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus.
    Hum Reprod Update. 1999 Jul-Aug;5(4):365-72 PMID: 10465526
  6. Effect of seminal plasma on implantation rates.
    Early Pregnancy. 1995 Mar;1(1):33-6 PMID: 9363233
  7. Mother's little helpers: mechanisms of maternal-fetal tolerance.
    Nat Immunol. 2006 Mar;7(3):241-6 PMID: 16482172
  8. Transforming growth factor beta--a mediator of immune deviation in seminal plasma.
    J Reprod Immunol. 2002 Oct-Nov;57(1-2):109-28 PMID: 12385837
  9. Does the absence or presence of seminal fluid matter in patients undergoing ovulation induction with intrauterine insemination?
    Hum Reprod. 1996 May;11(5):1008-10 PMID: 8671379
  10. Seminal plasma induces mRNA expression of IL-1beta, IL-6 and LIF in endometrial epithelial cells in vitro.
    Mol Hum Reprod. 2003 Dec;9(12):785-91 PMID: 14614040
  11. Intravaginal and intracervical application of seminal plasma in in vitro fertilization or intracytoplasmic sperm injection treatment cycles--a double-blind, placebo-controlled, randomized pilot study.
    Fertil Steril. 2009 Jan;91(1):167-72 PMID: 18249370
  12. Evaluation of high vaginal insemination at oocyte recovery in patients undergoing in vitro fertilization.
    Fertil Steril. 1989 Jan;51(1):135-8 PMID: 2910708
  13. Counter-current transfer in reproductive biology.
    Reproduction. 2005 Jan;129(1):9-18 PMID: 15615894
  14. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF.
    Hum Reprod. 2009 Jun;24(6):1427-35 PMID: 19228761
  15. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation.
    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2963-8 PMID: 12601161
  16. Semen activates the female immune response during early pregnancy in mice.
    Immunology. 2004 Jun;112(2):290-300 PMID: 15147572
  17. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells.
    Mol Hum Reprod. 2007 Jul;13(7):491-501 PMID: 17483528
  18. The effect of intercourse on pregnancy rates during assisted human reproduction.
    Hum Reprod. 2000 Dec;15(12):2653-8 PMID: 11098040
  19. Optimizing management of natural and artificial matings in swine.
    J Reprod Fertil Suppl. 1993;48:217-28 PMID: 8145206
  20. The influence of patient insemination on the implantation rate in an in vitro fertilization and embryo transfer program.
    Fertil Steril. 1986 Aug;46(2):252-6 PMID: 3732531
Article Info
Journal
Journal of assisted reproduction and genetics
Abbr.
J Assist Reprod Genet
ISSN
1573-7330
Published
2013-04-00
Epub
2013-00-12
Pages
569-74
Language
English
Region
Netherlands
NLM ID
9206495
PMCID
PMC3644137
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]